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Abstract   
 
Coatomer consists of two subcomplexes: the membrane-targeting, Arf1:GTP binding βγδζ-COP F-
subcomplex, which is related to the AP clathrin adaptors, and the cargo binding αβ’ε-COP B-
subcomplex.  We present the structure of the C-terminal µ-homology domain of the yeast δ-COP 
subunit in complex with the WxW motif from its binding partner, the ER-localised Dsl1 tether. The 
motif binds at a site distinct from that used by the homologous AP µ subunits to bind YxxΦ cargo 
motifs with its two tryptophan residues sitting in compatible pockets. We also show that the 
Saccharomyces cerevisiae ArfGAP homologue Gcs1p uses a related WxxF motif at its very C-
terminus to bind to δ-COP at the same site in the same way. Mutations designed on the basis of the 
structure in conjunction with ITC confirm the mode of binding and show that mammalian δ-COP 
binds related tryptophan-based motifs such as that from ArfGAP1 in a similar manner. We conclude 
that δ-COP subunits bind Wxn(1-6)[WF] motifs within unstructured regions of proteins that influence 
the lifecycle of COPI-coated vesicles, which is supported by the observation that in the context of a 
sensitising domain deletion in Dsl1p, mutating the tryptophan-based motif binding site in yeast 
causes defects in both growth and CPY trafficking/processing.   
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Significance statement: 
Eukaryotic cells contain many different organelles between which vesicles traffic material. COPI-
coated vesicles mediate essential, evolutionarily conserved retrograde trafficking pathways from the 
Golgi to the ER and within the Golgi. We have determined structures of the µ-homology domain 
(MHD) of the COPI δ-COP subunit in complex with tryptophan-based motifs from the ER-resident 
vesicle-docking/tethering complex Dsl1. This is the first mechanistic description of a tether/coat 
interaction; we furthermore demonstrate that this interaction plays a role in facilitating COPI-coated 
vesicle transport in vivo. Our works means that there is now a structure of each eukaryotic cell MHD 
and shows that MHDs are adaptable scaffolds, which can interact specifically with a range of 
proteins and phospholipids at different positions. 
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\body 
Introduction 
COPI vesicles mediate retrograde trafficking from the Golgi to the ER and within the Golgi 
(reviewed in (1-3)). The COPI vesicle coat consists of two major components, coatomer and the 
small GTPase ADP-ribosylation factor 1 (Arf1). Coatomer is a ~600 kDa heteroheptameric complex 
consisting of two linked sub-complexes, the βγδζ-COP F-subcomplex and the αβ’ε-COP B-
subcomplex, all conserved from yeast to humans.  
Recent studies have led to a model for COPI-coated vesicle formation in which the F-
subcomplex functions as a traditional Arf1:GTP effector but with two membrane attached Arf1:GTP 
molecules binding to quasi-equivalent sites on a single F-subcomplex, recruiting F-subcomplex and 
its associated B-subcomplex en bloc onto the membrane (4). Once the vesicle has budded from its 
donor membrane, an Arf GTPase activating protein (ArfGAP) catalyses the hydrolysis of GTP on 
Arf1 and the Arf1:GDP dissociates from the membrane, followed later by the dissociation of the 
coatomer complex that was bound to the transport vesicle (5). ArfGAPs have also been proposed to 
function at different stages in vesicle biogenesis, as both terminators and, during an earlier ‘cargo 
editing’ step, as effectors (reviewed in depth in (6)). In the final stages of its life, a COPI-coated 
vesicle docks with the ER via the Dsl1 tethering complex, completes uncoating and, finally, 
undergoes SNARE-mediated fusion with the ER (7-9). 
 The two main ArfGAPs associated with COPI-dependent retrograde transport in yeast are 
Gcs1p and Glo3p. These proteins can at least partially substitute for one another in COPI-vesicle 
mediated transport, although Glo3p, which binds the γ-COP appendage domain, has been proposed 
to play the more significant role (10-12). Cassel and coworkers have demonstrated, for mammalian 
ArfGAP1, that a di-tryptophan motif (WxxxxW) located within the unstructured C-terminus of the 
protein can bind to the mammalian δ-COP C-terminal µ-homology domain (MHD) (13). Intriguingly 
this tryptophan motif resembles a proposed yeast δ-COP binding motif, termed δL, which was 
identified by yeast-2-hybrid screening and then discovered in a cytosolic protein which at that time 
was of uncertain function in COPI vesicle trafficking (14). Subsequently similar motifs were identified 
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in the central low complexity region (the so-called ʻlassoʼ) of the Dsl1p subunit of the yeast Dsl1 
tethering complex (7-9, 15). Here we reveal the structure of S. cerevisiae δ-COP MHD and the basis 
for its binding to di-tryptophan-based motifs from Dsl1p, and also demonstrate that a related WxxF 
motif from the very C-terminus of Gcs1p binds at the same site on δ-COP. The functional relevance 
of this binding site on δ-COP is indicated by the observation that mutations in the site that abolish 
motif binding can affect CPY trafficking/maturation and cause growth phenotypes. 
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Results 
 
Structure of δ-COP MHD in complex with Dsl1p WxW motif 
Isothermal titration calorimetry (ITC) was used to test the ability of bacterially expressed 
yeast δ-COP MHD (residues 282-546, see Figure 1A) to bind di-tryptophan peptides derived from 
the yeast Dsl1p lasso (residues 378-488). Low micromolar KD’s (~10 µM) were observed for the 
binding of δ-COP MHD to peptides with spacing WxW and WxxxW (Figure 1B). Di-tryptophan 
peptides with 4, 5 or 6 residues between the tryptophans also bound, with KD’s between 10 and 50 
µM (Figure S1). These results suggest that the presence of two relatively closely spaced tryptophan 
side chains is the main determinant for binding.  
Yeast δ-COP MHD was co-crystallised with the strongest binding peptide, corresponding to 
the WxW motif in the Dsl1p lasso (DDWNWE(SeMet)ED) (N.b. the valine in the native sequence 
was substituted with a selenomethionine to aid identification of the peptide orientation – this peptide 
bound with a similar affinity to a native sequence peptide (Figure S1)). The structure was 
determined at 2.8 Å resolution by selenomethionine multiwavelength anomalous dispersion 
methods (MAD) (Table S1, Figure S2 and Materials and Methods for detailed description of 
structure determination).  
As predicted, yeast δ-COP MHD resembled µ1-4 adaptins and Syp1p, being constructed of 
17 β-strands arranged in two inter-linked β-sandwich subdomains (16-20) (Figure 1C). One striking 
feature of the δ-COP MHD structure is its large negative electrostatic surface potential, which is 
conserved across species and is therefore presumably functionally important (Figure 1D).  This 
global feature is in marked contrast to the MHDs of AP1 and especially AP2, which are extremely 
positively charged (Figure 1D).  The role of these positively charged patches in AP MHDs is to 
mediate binding to negatively charged, organelle-specific PIPs : PtdIns(4,5)P2 in the case of AP2 at 
the plasma membrane and presumably PtdIns(4)P in the case of the trans-Golgi network (TGN) 
(21-23). By analogy the δ-COP MHD could also be involved in specificity of COPI membrane 
recruitment and/or of COPI-coated vesicle docking (see Discussion). 
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All nine residues of the Dsl1p lasso peptide were clearly visible in electron density maps, 
binding at a site comprising δ-COP MHD strands 4 and 6 and the loop between strands 5 and 6. 
The identities of the residues and inter-strand loop length at this site are well conserved from yeast 
to mammals (see figure 1D and S3). The WxW peptide binding occurs at a position adjacent to and 
slightly overlapping with the binding site of the YKFFE sequence of APP to µ4 MHD (17), but at a 
completely different site and in fact on an orthogonal face from the binding of YxxΦ signals to AP 
MHDs (16) (Figure 1C).  
The WxW peptide binds in an extended conformation with the three hydrophobic residues 
binding into three complementary hydrophobic pockets (Figure 2A, figure S2). The N-terminal 
tryptophan of the WxW motif in the Dsl1p lasso, Trp-413, is deeply buried in ‘pocket 1’ (Figure 2B). 
Structure-based superposition shows that pocket 1 in δ-COP is equivalent to the pocket in µ4 in 
which Phe-690 (YKFFE) in APP is buried (Figure S4) (17). The C-terminal tryptophan, Trp-415 is 
deeply buried in a hydrophobic pocket (‘pocket 2’) created by the loop between strands 5 and 6, 
which is significantly longer than in other MHDs (15 residues vs. for example 4 in µ2). The 
selenomethionine in the DDWNWE(SeMet)ED) peptide (valine in the native sequence) is buried in 
the third hydrophobic pocket (‘pocket 3’), which could be considered as an extension of pocket 2. 
Aspartate residues, often found adjacent to the tryptophan residues in δ-COP MHD binding 
sequences, may serve to funnel ligands towards the binding site, which is the only significant non-
negatively charged patch on the otherwise negatively charged δ-COP MHD surface (Figure 1D). 
 We used this structure as a molecular replacement model to solve at 1.8 Å resolution a 
different (and merohedrally twinned) crystal form of yeast δ-COP MHD in complex with the 
equivalent non-SeMet peptide DDWNWEVED (Table S2). The structures were essentially identical, 
with the peptides bound in the same way (Figure S2). We were also able to solve another co-crystal 
structure of yeast δ-COP MHD in complex with a peptide corresponding to the W455xxxW459 motif in 
Dsl1p (Table S2). In this structure, the motif also bound at the same site and most likely in the same 
orientation, although low occupancy of the peptide prevented detailed analysis of the binding 
(Figure S2). A final crystal form of yeast δ-COP MHD, crystallised without peptide, was determined 
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by molecular replacement (Table S2). This structure showed that the binding of peptide had no 
discernable effect on the structure (Figure S5); i.e., binding occurs to an effectively rigid template.   
 
Mutagenesis of the tryptophan-based motif binding site on δ-COP. 
Most (8 of 12) of the S. cerevisiae δ-COP residues that contact the di-tryptophan peptide 
motif, including His-350 and Arg-384, are conserved across species (Figure S3). We were able to 
validate the peptide binding mode observed in the crystal structure experimentally by using a double 
point mutant (H350A, R384S) that, while fully folded as determined by circular dichroism and gel 
filtration, eliminates the cation-π interactions between His-350 and Arg-384 and the indole rings of 
Trp-415 and Trp-413, respectively. As predicted, the double point mutant no longer bound the WxW 
peptide (KD > 300 µM, Figure 2C). In addition, mammalian δ-COP MHD bearing mutations 
corresponding to yeast H350A, R384S (H330A K363S) no longer bound to the WxxxxW binding 
peptide from its ligand ArfGAP1, confirming that the mode of di-tryptophan motif binding is 
conserved from yeast to mammals (Figure S1). 
 
Studying the binding of tryptophan based motifs to δ−COP in vivo. 
The yeast δ-COP H350A, R384S (HARS) mutant provided us with a tool for assessing the 
functional role of the δ-COP:Dsl1p lasso interaction in vivo. When wild-type δ-COP was replaced by 
the HARS double mutant to abolish the δ-COP:Dsl1p interaction, yeast grew normally. This result is 
not unexpected based on the previous finding that the Dsl1p lasso is functionally redundant with 
another region of Dsl1p, the highly-conserved C-terminal E domain (9, 24), for COPI-mediated 
transport: yeast containing either a deletion of the entire lasso region or a deletion of the E-domain 
grow normally (24). Strikingly, yeast lacking the Dsl1p E domain – and therefore rendered 
dependent upon the Dsl1 lasso for COPI-dependent transport and hence viability – displayed 
marked growth rate defects when lasso binding was compromised by the δ-COP HARS mutations 
(Figure 3A). This growth defect was accompanied by a major defect in carboxypeptidase Y (CPY) 
trafficking/maturation at 37oC, and to a lesser degree at 34oC (Figure 3B), suggesting that δ-COP 
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MHD is involved in an interaction important to maintain correct vesicular trafficking between Golgi 
and ER.   
 
Structure of δ-COP µ-homology domain with a WxxF motif from yeast Gcs1p: 
Curiously, mammalian and yeast δ-COP MHDs are thought to bind different di-tryptophan-
containing ligands. In mammals, ArfGAP1 but not the Dsl1 (also called NRZ) complex is proposed 
as the functionally relevant δ-COP MHD ligand; indeed, the mammalian Dsl1p homologue ZW10 
lacks a tryptophan-rich lasso. In yeast, Dsl1p but not the ArfGAP1 orthologue Gcs1p has been 
proposed as the δ-COP MHD ligand. In light of our results, we re-examined the Gcs1p sequence 
from S. cerevisiae and found a WxxF at the very C-terminus that is conserved in most yeasts 
(Figure 4A).  
A WxxF peptide from Gcs1p (residues 345-352; DEDKWDDF) bound to δ-COP MHD with an 
affinity similar (KD = ~10 µM) to that of di-tryptophan peptides (Figure 4C). Moreover, a complex of 
δ-COP MHD and the same WxxF peptide crystallised in a new crystal form that diffracted to 2.5 Å 
(Table S1). Electron density representing D347KWDDF352 residues in the peptide was clearly visible, 
showing that the peptide binds at the same site and in the same orientation as the Dsl1p WxW 
peptide (Figure 4B, figure S2). As expected, the C-terminal Phe residue occupies pocket 2 and the 
(H350A, R384S) mutation in δ-COP MHD abrogates WxxF peptide binding (Figure 4C). The WxxF 
peptide is, however, slightly displaced relative to the di-tryptophan peptides (Figure 4D), partly to 
accommodate the different number of intervening residues but also to allow the formation of a salt 
bridge between the C-terminus of the peptide and the side chain of Lys-371 (Figure 4B). In the 
absence of Glo3p, cells expressing Gcs1p with its WxxF mutated grew more slowly than cells 
expressing wild type Gcs1p, implying an in vivo role for the WxxF motif (Figure S6A); however, CPY 
sorting was compromised to a similar extent when either WT or mutant Gcs1p with its terminal 
WDDF mutated to ADDA were expressed in the absence of Glo3p (Figure S6B).   
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Discussion: 
 
We have described the structure of the S. cerevisiae δ-COP MHD and the basis for its 
binding to di-tryptophan motifs found in Dsl1p (WxW and WxxxW; first reported in (7)) and to a 
newly identified WxxF motif found at the C-terminus of the ArfGAP protein Gcs1p. Interestingly in 
the fission yeast S. pombe the δ-COP gene is actually missing its MHD altogether and this is the 
one yeast that lacks a WxxF sequence at the very C-terminus of its Gcs1p homologue (Figure 4A) 
and also lacks a Dsl1p homologue (25), perhaps reflecting the loss of the evolutionary pressure to 
maintain one half of an interacting pair of sites when the other is absent. 
Unlike AP MHD ligands, neither Gcs1p nor Dsl1p are transmembrane proteins but are 
vesicle coat assembly/disassembly factors, indicating a fundamentally different role for δ-COP MHD 
as compared with transmembrane cargo sorting AP MHDs.  This observation is in line with the fact 
that a third yeast protein proposed as a tryptophan-based motif containing δ-COP MHD ligand 
originally termed δL, and now named Cex1p (14), has a mammalian homologue Scyl1, that has now 
been shown to be a cytosolic protein implicated in Golgi to ER transport (26). Since binding of 
similar strength can be detected to WxxxxW, WxxxxxW and WxxxxxxW constructs (Figure S1; note 
however that the last of these binds less tightly, with KD ~50 µM), the δ-COP MHD binding motif can 
be redefined as Wxn(1-6)[WF], which may aid in identifying new accessory factors for COPI-coated 
vesicle formation/disassembly. Our in vivo data indicate that growth defects and CPY 
trafficking/processing defects can be brought about by disrupting δ-COP MHD Wxn(1-6)[WF] motif 
binding but only in a sensitised system; e.g., deletion of Dsl1p E-domain or absence of Glo3p. The 
need for multiple mutations to reveal phenotypic alterations likely reflects high levels of redundancy 
in this important cellular transport route such as the binding of the other ArfGAP Glo3p by F-
subcomplex γ-COP appendage (12) and the binding of the Dsl1p lasso by α-COP (7).   
By analogy with AP2 and AP1 (21, 27, 28), membrane recruitment of the coatomer might be 
expected to trigger an Arf1:GTP-driven conformational change in the F-subcomplex from an inactive 
closed form to an ‘open’ form (4). However, the open form of F-subcomplexes attached to a 
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membrane in a coat has recently been demonstrated to be even more extreme than the open 
conformation of AP complexes (27, 28) and is now referred to as ‘hyper-open’ (29). The hyper open 
conformation of coatomer, in which δ-COP MHD is on the very outside of the coat away from the 
membrane, would be maintained in the vesicle coat so long as coatomer was bound to Arf1:GTP. 
After nucleotide hydrolysis and Arf1:GDP disengagement, the F-subcomplex would likely revert to a 
more closed form; however, due to the COPI B-subcomplex binding to KKxx and KxKxx 
transmembrane cargoes (29-31), the coat should not dissociate from the vesicle surface 
immediately (5). Assuming that the F-subcomplex adopts a ‘closed’ conformation similar to that of a 
cytosolic AP complex, modelling suggests that the Wxn(1-6)[WF] binding site on δ-COP should be 
accessible when the F-subcomplex is closed (Figure S7). This situation contrasts with the 
unavailability of YxxΦ motif binding site on the µ subunits of closed AP complexes (21, 32). EM 
tomography suggests that δ-COP MHD Wxn(1-6)[WF] binding site remains accessible in the ‘hyper 
open’ membrane-associated conformation, indicating it possesses no switching mechanism to 
regulate ligand binding. This likely reflects the different roles of the MHDs in COPI and AP 
complexes. APs must bind YxxΦ motifs only when the APs are on the membrane so they do not 
bind erroneously to YxxΦ motifs in cytosolic proteins. By contrast, COPI needs to bind cytosolic, 
vesicle-coat assembly/disassembly factors throughout a COPI-coated vesicle’s life cycle: Gcs1p 
during the early stages of COPI-coated vesicle assembly for a possible role in cargo selection 
editing, Cex1p at an undefined stage, and Dsl1p in the latter stages for docking and ultimately 
fusion with target membranes.  
The remarkable electronegativity of δ-COP MHD surfaces could, by analogy to the 
homologous AP MHD surfaces that target APs to PIP-rich and hence negatively charged 
membranes, function in membrane recruitment specificity. However, since the cis- and medial Golgi 
membranes are not positively charged but rather much less negatively charged than the late Golgi, 
such a role would need to be achieved through inhibiting recruitment to the more negatively charged 
membranes of the late-Golgi and TGN. The reduction in negative charge of the cis- and medial 
Golgi relative to the TGN and late Golgi is the result of two factors. Firstly, the negatively charged 
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PtdIns(4)P is concentrated in the later Golgi due to the constant cycling of the PtdIns(4)P 
phosphatase Sac1 between the cis-Golgi and ER (33, 34). Secondly, phosphatidyl serine, another 
major negatively charged phospholipid, is mostly located only in the inner leaflet of the ER and cis-
Golgi membranes whereas it is found more in the outer leaflet of compartment membranes later in 
the secretory pathway (35). Interestingly both β’-COP (30) and α-COP (31) juxtamembrane surfaces 
are similarly highly electronegative, and could thus also contribute to selective membrane 
recruitment of coatomer.  
However, in a recent ground-breaking electron tomographic reconstruction of COPI-coated 
vesicles (29), Dodonova et al.’s model suggested that δ-COP MHD is actually on the outside of 
coat, being the furthest part of the COPI coat from the membrane surface. One intriguing possibility 
is therefore that the high global negative charge of δ-COP may have a role in contributing to 
specificity of target membrane fusion of COPI-coated vesicles in that δ-COP could inhibit close 
apposition and hence fusion with more negatively charged membranes such as the late Golgi/TGN, 
but not inhibit contact with the comparatively uncharged membranes of the cis-Golgi and ER.  Such 
a mechanism could consequently impart retrograde directionality to COPI vesicle transport through 
the Golgi towards the ER and may also involve α-COPCTD/ε-COP subcomplex, which is similarly 
both highly negatively charged (36, 37) and located on the outside of the COPI coat (29). It should 
be noted that for such a scenario to operate, a significant proportion of coatomer must indeed stay 
associated with vesicles right up to their docking step to allow Dsl1 complex-mediated tethering of 
COPI-coated vesicles to occur (5, 15). 
Finally, comparing the structures of MHDs of the µ subunits in AP complexes and the δ-COP 
subunit of coatomer indicates that the Wxn(1-6)[WF] motif binding is unique to δ-COP since both the 
residues and length of loops involved in Wxn(1-6)[WF] motif binding in δ-COP are not significantly 
conserved in the MHDs of AP complexes or TSET (38). Further, the proteins containing those 
motifs are cytosolic coat assembly/disassembly factors rather than membrane embedded cargo and 
as such δ-COP MHDs may play a role more analogous to that of the MHDs of muniscin family 
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members such as Syp1p and its mammalian homologues FCHo1 and FCHo2 (39) than to that the 
MHDs of AP complexes in CCV formation.  
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Materials and Methods: 
Protein expression and purification: 
δ-COP µ-homology domain (282-546) from S. cerevisiae was expressed in BL21(DE3)plysS (for 
native protein), or in B834(DE3)plysS (for selenomethionine-substituted protein) for 18-20 hr at 
20°C after induction with 0.5 mM IPTG as a GST-fusion protein. GST-δ-COP-MHD was affinity 
purified using glutathione sepharose. Following washing with 20 mM HEPES pH 7.5, 700 mM NaCl, 
and 5 mM β-ME, δ-COP MHD was eluted through overnight cleavage of the GST-fusion protein with 
Prescission protease at 4°C. δ-COP-MHD was further purified by size-exclusion chromatography 
(SEC) using a Superdex SD75 preparative column in 20 mM HEPES pH 7.5, 200 mM NaCl, and 5 
mM DTT.  
Isothermal titration calorimetry: 
All ITC experiments were carried out at 20 °C, with proteins and peptides in 50 mM HEPES pH 7.5, 
200 mM NaCl, 5 mM β-ME with δ-COP MHD at 100 µM. All experiments were carried out at least 
three times, with appropriate standard deviations reported. 
Structure determination of δ-COP MHD with Dsl1p WxW and Gcs1p WxxF peptides: 
The Dsl1p selenomethionine-substituted WxW peptide (DDWNWE(SeMet)ED) was mixed with 
selenomethionine-substituted δ-COP (282-546) W404A (30 mg/ml) at 2:1 molar ratio, and 
crystallised in in 0.1 M HEPES-Na pH 7.0, 0.15 M (NH4)2SO4, 21% (w/v) PEG-3350. Crystals were 
cryoprotected with 15% glycerol and a three-wavelength MAD dataset was collected at the selenium 
edge. The best crystal diffracted to 2.8 Å and belonged to space group P1 and the data processed 
and structure solved as described in Supplementary information and Tables S1 and S2..  
The Gcs1p WxxF peptide (DEDKWDDF) was mixed with selenomethionine-substituted δ-COP (282-
546) W404A (20 mg/ml) at 2:1 molar ratio, and crystallised in 0.1 M Tris-HCl pH 8.5, 0.15 M 
magnesium chloride, 26% (w/v) PEG-4000. Crystals were cryoprotected with 15% glycerol and data 
were collected to 2.5 Å (space group P212121). The structure was solved by molecular replacement 
using one molecule of the previously determined δ-COP MHD structure (in complex with the 
DDWNWE(SeMet)ED peptide).  
 15 
Yeast Methods: 
Heterozygous DSL1/dsl1H701Stop::natMX (24) was transformed with a linearized plasmid containing 
ret2H350A,R384S::URA3. Diploid cells were sporulated and dissected to obtain the double mutant strain. 
Growth assays were performed as previously described (8). CPY secretion assays and 
immunoblots testing CPY trafficking/processing were performed as previously described (40, 41), 
using rabbit α-CPY antibodies generously provided by Karin Römisch (Saarland University, 
Germany. The following yeast mutants were used as positive controls to assay for trafficking 
phenotypes: sec18-1 for p1-CPY accumulation (i.e. an ER block); vps35Δ for possible 
vacuolar protein sorting defects (i.e. p2-CPY accumulation and loss of mCPY). 
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Figure 1 – Structure of yeast δ-COP MHD with yeast Dsl1p WxWxφ  motif 
 
(A) Schematic representation of interactions between δ-COP and Dsl1p.  
(B) ITC experiments showed that yeast δ-COP MHD (282-546) binds to di-tryptophan peptides 
corresponding to the WxW (DDW413NW415EVED) and WxxxW (ENAW455DEAW459AIDEC) motifs in 
yeast Dsl1p with KD’s of 11 ± 2 and 16 ± 1 µM (SD, N=3) respectively at a 1:1 stoichiometric ratio.  
(C) Crystal structure of yeast δ-COP MHD with a selenomethionine substituted Dsl1p WxW peptide 
(DDWNWE(SeMet)ED) showing that di-tryptophan motifs bind to δ-COP at a position similar to the 
binding of the YKFFE of APP to µ4 MHD (3L81) (17), but at a completely different site from the 
binding of Yxxφ signals to AP MHDs (1BXX) (16, 18, 19). Final refined 2mFO-DFC density contoured 
at 1.2σ, and mFO-DFC difference density at ±3.0σ for the peptide is shown inset. The total buried 
area of the interface between δ-COP and the WxWx(SeMet) peptide is 1354 Å2, as calculated by 
the PISA server (http://www.ebi.ac.uk/pdbe/pisa/). 
(D) The Consurf server (http://consurf.tau.ac.il/) was used to create a surface representation of 
evolutionary conservation of residues in δ-COP MHD (D), based on an alignment from yeast to 
humans using ClustalO (see also figure S3). The tryptophan-based motif binding site is the 
outstanding feature of this conservation surface representation. Surface representations of the 
electrostatic potential of δ-COP MHD and µ2 MHD (E), highlights that δ-COP MHD is largely 
negative (contoured from -0.5V (red) to +0.5V (blue)). The di-tryptophan motif binding site on δ-COP 
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MHD is relatively positive compared to the remainder of the domain. The conservation surface 
representation shows that the negatively charged surface on the backside of subdomain B is also 
highly conserved. 
 
  
 21 
Figure 2 – Structural details of Dsl1p WxW peptide bound to δ-COP MHD 
 
(A) Dsl1p WxWx(SeMet) peptide (DDWNWE(SeMet)ED) binds to δ-COP MHD in an extended 
conformation with the three hydrophobic residues binding into three complementary pockets 
(labelled).  
(B) Surface representation of the di-tryptophan motif binding site in δ-COP MHD coloured from high 
(dark green) to low (white) hydrophobicity. The three hydrophobic pockets into which the 
hydrophobic residues in the peptide bind can be clearly seen. 
(C) ITC showing that a combination of H350A and R384S mutations (highlighted in dark red in A 
and B) abolish (KD > 300 µM) (red triangles) the interaction of the Dsl1p WxW peptide 
(DDWNWEVED) with δ-COP MHD (black squares) (KD = 11 ± 2 µM) (SD, N=3). Data for mutant is 
offset for clarity.  
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Figure 3 - ret2(HARS)/dsl1-ΔE mutant cells show defects in growth and in CPY trafficking. 
 
(A) Isogenic strains bearing mutations at either the DSL1 or RET2 (δ-COP) gene loci, labelled as 
dsl1-ΔE and ret2(HARS), were serially diluted, spotted and grown at the indicated temperatures for 
48 hr. The double-mutant harboring both the ret2(HARS) and dsl1-ΔE allele was lethal at 37oC (no 
colonies after one week) but viable at lower temperatures, albeit having a slight growth defect.  All 
combinations are shown in biological duplicate. 
(B) Cells of strains as indicated at the top of the figure were grown to mid-log at 30oC in YEPD 
medium, and then shifted for 2 hr to either 34oC or 37oC. Glassbead-extracts of collected cells were 
separated by 7.5% SDS-Page and probed with α-CPY antibodies (40). Positions of p1 (ER), p2 
(Golgi), and mature (vacuolar) forms of CPY are indicated. Note p1-CPY accumulation in 
ret2(HARS) dsl1-ΔE double-mutant cells at 34oC and more strongly at 37oC, but not single mutant 
cells. 
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Figure 4 – Structural details of Gcs1p WxxF peptide bound to δ-COP MHD 
 
(A) Alignment of the C-terminal region of Gcs1p from different yeasts showing that the WxxF motif 
at the very C-terminus is conserved in all apart from S. pombe. δ-COP in S. pombe does not contain 
a MHD (see schematic); lack of selective pressure means the WxxF in the Gcs1p homologue in S. 
pombe has been lost. 
(B) Gcs1p WxxF peptide (DEDKWDDF) binds to δ-COP MHD at the same site as binding of the 
Dsl1p WxW peptide with Trp-349 in pocket 1 and Phe-352 in pocket 2.  
(C) ITC showing that a combination of H350A and R384S mutations (highlighted in dark red in B) 
also abolish (KD > 300 µM) (red triangles) the interaction of the Gcs1p WxxF peptide (DEDKWDDF) 
with δ-COP MHD (black squares) (KD = 11 ± 1 µM at a 1:1 stoichiometric ratio (SD, N=3)). Data for 
mutant is offset for clarity.  
(D) Superposition of the two δ-COP MHD tryptophan-based peptide co-crystal structures showing 
that the N-terminal tryptophan of both peptides binds into pocket 1, and the C-terminal 
tryptophan/phenylalanine into pocket 2. Superposition is within the tryptophan motif binding site 
(residues 348-355, 363-384). For clarity only the model of δ-COP is shown from the Gcs1p WxxF 
peptide co-crystal structure, and only the hydrophobic residue side chains within the peptides are 
shown.  
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Figure S1 - δ-COP MHD binds to W(x)nW motifs where n = 4, 5 and 6 
 
(A) ITC experiments showed that yeast δ-COP MHD (282-546) (W404A) binds to W(x)nW peptides 
where n = 4, 5 and 6 with KD’s of 10, 21 ± 2 and 38 ± 2 µM (SD, N=3) respectively at a 1:1 
stoichiometric ratio.  
(B) ITC showing that δ-COP MHD (282-546) (W404A) binds to a peptide (DDWNWE(SeMet)ED) 
corresponding to the WxW motif in the Dsl1p lasso, in which the valine in the native sequence was 
substituted with a seleno-methionine to aid identification of the peptide orientation. The peptide 
bound with a similar affinity to the native peptide (Figure 1B) (KD = 4 ± 1 µM vs. 11 ± 2 µM (SD, 
N=3)) at a 1:1 stoichiometric ratio. The slightly higher affinity of the seleno-methionine derived 
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peptide is presumably due to additional van der Waals interactions of the methionine side chain with 
hydrophobic pocket 3, compared to the native valine side chain (Figure S2). 
(C) ITC showed that a combination of H330A and K363S mutations in human δ-COP (homologous 
to the H350A and R384S mutations in yeast δ-COP, see figure S3) abolishes (KD > 300 µM) (red 
squares) the interaction of the human ArfGAP1 WxxxxW peptide (TDDGWDNQNW)) with δ-COP 
MHD (W381A) (black squares). This shows that the human Gcs1p-orthologue ArfGAP1 WxxxxW 
peptide (TDDGWDNQNW) binds to human δ-COP MHD at the very same site as yeast Gcs1p 
WxxF peptide binds to yeast δ-COP MHD. Data for H330A K363S W381A mutant is offset by +0.25 
µcal/sec for clarity.  
 
  
 27 
Figure S2 – Structural overview of δ-COP MHD binding to tryptophan-based motifs 
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(A-I) Electron density from δ-COP MHD in complex, with the Dsl1p WxWx(SeMet) peptide (A-C), 
with the Dsl1p WxxxW peptide (D-E), with the Dsl1p WxWxV native peptide (F-G), and finally with 
the Gcs1p WxxF peptide (H-I). Part of the experimentally phased, solvent flattened electron density 
map from autoSHARP (42) highlighting the clear protein-solvent boundary (A-B), and the clear 
density for the peptide (B-C) (1.0σ). (C) An anomalous difference map (solid) (±3.0σ, + = yellow, - = 
red) (clipped around peptide) shows the large positive peak representing the selenomethionine in 
the WxWx(SeMet) peptide. 2mFO-FC (0.8σ) and mFO-FC (±2.5σ) density maps representing the 
WxxxW peptide, before peptide model building (D) and after (E), showing that the peptide 
occupancy is low, and the density difficult to interpret; however the peptide most likely binds in the 
same orientation as the other peptides. 2mFO-FC (0.8σ) and mFO-FC (±3.0σ) density maps 
representing the native Dsl1p WxWxV peptide before peptide model building (F), and after (G), 
showing the clear density for the two tryptophans. 2mFO-FC (1.0σ) and mFO-FC (±3.0σ) density 
maps representing the Gcs1p WxxF peptide, before peptide model building (H) and after (I), 
showing the clear density for the tryptophan and phenylalanine. 
 
Figure S3 – Conservation of the tryptophan-based motif binding site in δ-COP MHD 
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The Consurf server (http://consurf.tau.ac.il/) was used to create a surface representation of 
evolutionary conservation of residues in δ-COP MHD (also shown in figure 1D), based on an 
alignment from yeast to humans using ClustalO (shown here). The region that forms the tryptophan-
based motif binding site in this alignment is shown here. Residues directly involved in the binding 
site are highlighted above the alignment in red. The tryptophan-based motif binding site is the 
outstanding feature of the conservation surface representation, indicating its importance. The Dsl1p 
WxW peptide is shown. Note conservation of the length of the loop between strands 5 and 6. 
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Figure S4 - δ-COP MHD binds to tryptophan-based motifs at a similar site to the binding of 
µ4 to the YKFFE motif 
 
Surface representations of the YKFFE binding site in µ4 MHD (3L81) (17), and the tryptophan-
based motif binding site in δ-COP MHD coloured from high (dark green) to low (white) 
hydrophobicity with the relevant peptides shown (A). This shows that ‘pocket 1’ (pocket between 
His-350 and Arg-384) in δ-COP is equivalent to the pocket in µ4 in which Phe-690 (YKFFE) in the 
APP motif is buried. This is evident following superposition of µ4 and δ-COP MHDs; three different 
angles of the superposed peptides are shown in (B). 
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Figure S5 – Binding of tryptophan-based motifs to δ-COP MHD through a ‘lock and key’ 
mechanism 
 
Superposition of δ-COP MHD bound to peptide (dark green) (of the δ-COP: Dsl1p WxWx(SeMet) 
peptide structure), with a molecule not bound to peptide (light green), showing that the binding of 
peptide has no discernable effect on the structure. The only clear difference is the different 
conformation of leucine 380 side chain, creating a larger hydrophobic pocket into which the second 
tryptophan binds (pocket 2). 
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Figure S6 – Compromised Gcs1p binding to δ-COP MHD impairs yeast cell growth. 
 
(A) Yeast cells carrying simultaneous chromosomal deletions of both the ArfGAP genes GCS1 and 
GLO3 are unviable, unless expression of one of these ArfGAPs is driven from a plasmid. Galactose-
dependent expression of Glo3p from the GAL10 promoter can keep double-mutant cells growing in 
media containing galactose, but not in galactose-free e.g. glucose-containing media. Individual 
plasmid transformants were serially diluted, spotted onto glucose-containing plates and incubated at 
30oC for 48 hours. Note that the mutant Gcs1-AA protein (with the W349A, F352A substitutions) 
cannot sustain optimal yeast colony growth in galactose-free media, in comparison with and in 
contrast to wild-type Gcs1p. 
(B) Cells of strains as indicated at the top (the RET2 gene encodes yeast δ-COP) were grown to 
mid-log phase in YEPD liquid culture at 30oC, and then shifted for 2 hr to 34oC or 37oC, resp. 
Glassbead-extracts of collected cells were separated by 7.5% SDS-Page and probed with anti-CPY 
antibodies (see Duden et al., 1994). Positions of p1(ER), p2 (Golgi), and mature (vacuolar) forms of 
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CPY are indicated. glo3Δ/gcs1-WF single- and the glo3Δ/gcs1-AA double-mutant cells display a 
strong defect in ER-to-Golgi transport of CPY at 37oC, but not 34 oC. Also note the absence of a 
discernable difference between these mutants with regards to their CPY processing ability. 
Extensive attempts to demonstrate the physical interaction between coatomer and Gcs1p in vivo 
have proved technically impossible, since the levels of detergent needed to reduce non-specific 
background binding to acceptable levels (>1% IGEPAL) abrogate the interaction in vitro. This likely 
reflects that the interaction is mainly mediated by hydrophobic side chain interactions that will be 
readily outcompeted by detergent molecules. 
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Figure S7 – Docking of δ-COP MHD structure into the AP2 locked/closed form  
 
Surface representation of the AP2 locked form (2VGL) (21), and docking of the δ-COP MHD (C-δ-
COP)-Gcs1p WxxF peptide co-crystal structure into the AP2 locked form based on superposition of 
C-δ-COP with C-µ2. The Gcs1p WxxF peptide is shown as spheres. Note the significant occlusion 
of the Yxxφ binding site in µ2 in the AP2 structure, but the fully accessible WxxF binding site in δ-
COP. 
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Table S1 - Data collection and refinement statistics 
 δ-COP MHD W404A SeMet with Dsl1p WxWx(SeMet) peptide δ-COP MHD W404A 
SeMet with Gcs1p WxxF 
peptide  High Remote  Inflection Peak  
Data Collection     
Beamline Diamond I03 Diamond I04-1 
Space group P1 P212121 
Wavelength (Å) 0.97631 0.97961 0.97949 0.9173 
Cell dimensions (Å)     
a, b, c (Å) 68.4, 79.4, 163.4 70.1, 84.9, 148.6 
α, β, γ (°) 79.7, 87.5, 83.6 90.0, 90.0, 90.0 
Resolution range (Å)a 78-2.80 (2.85-2.80) 78-2.90 (2.90-2.97) 78-2.80 (2.85-2.80) 55.9-2.45 (2.55-2.45) 
Rmergeab 0.126 (1.208) 0.090 (1.076) 0.128 (1.855) 0.105 (0.990) 
Rmeasac 0.149 (2.340) 0.127 (1.574) 0.151 (2.214) 0.114 (1.086) 
CC1/2ad 0.996 (0.537) 0.996 (0.532) 0.996 (0.504) 0.998 (0.508) 
Mean I/σI a 12.9 (1.1) 10.4 (1.0) 11.5 (1.0) 12.5 (1.9) 
Completeness (%) a 97.8 (97.4) 83.7 (93.0) 97.9 (97.4) 99.9 (99.9) 
Multiplicity a 7.0 (7.2) 3.7 (3.7) 7.0 (7.2) 6.5 (5.8) 
Wilson <B> (Å2) 86   55.7 
Anomalous completeness 
(%) a 96.6 (96.6) 77.6 (87.5) 96.7 (96.9) 99.7 (98.4) 
CC1/2 on Δanom (inner bin) a 0.191 (0.000) 0.183 (0.011) 0.461 (0.031) 0.205 (0.021) 
Phasing     
Rcullis isomorphous  - 0.705 0.713  
Rcullis anomalous  0.945 0.962 0.879  
Overall Phasing Power 
isomorphous - 0.470 0.352  
Overall Phasing Power 
anomalous 0.525 0.387 0.775  
Figure of merit (pre-/post-
solvent flattening) 0.293/0.887  
     
Refinement      
Resolution range (Å) 77.6-2.80   55.9-2.45 
No. of reflections 76847   31880 
Rwork/Rfree 0.189/0.234   0.193/0.258 
Number of atoms     
Protein 16445   6156 
Ligand/ion 696   110 
Water 554   257 
B-factors (Å2) 92.3   32.4 
Rmsd from ideal values     
Bond lengths (Å) 0.012   0.013 
Bond angles (°) 1.526   1.596 
Ramachandran Plot     
Favoured region (%) 97.4   97.5 
Allowed (%) 1.8   2.1 
Outliers (%) 0.8   0.4 
Rotamer outliers (%) 2.9   4.8 
C-beta outliers 4   1 
 
a Values in parentheses are for the highest resolution shell. bRmerge = Σ(Ihl - <Ih>)/Σ(Ihl) where <Ih> is the mean intensity of unique reflection 
h, summed over all reflections for each observed intensity Ihl. cRmeas = Σ(n/n – 1)1/2 (Ihl - <Ih>)/Σ(Ihl) where n is the number of observations 
for unique reflection h with mean intensity <Ih>, summed over all reflections for each observed intensity Ihl. dCC1/2 is the correlation 
coefficient on <I> between random halves of the dataset. Δanom, anomalous difference I+ - I-. 
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Table S2 - Data collection and refinement statistics 
 
 δ-COP MHD W404A native with Dsl1p WxWxV peptide δ-COP MHD WT native 
δ-COP MHD W404A 
SeMet with Dsl1p 
WxxxW peptide 
 Merohedrally twinned   
Data Collection    
Beamline Diamond I03 Diamond I02 Diamond I04-1 
Space group P3121 P212121 P3121 
Wavelength (Å) 0.96863 1.0 0.91732 
Cell dimensions (Å)    
a, b, c (Å) 72.8, 72.8, 343.3 86.9, 148.6, 222.7 72.9, 72.9, 340.9 
α, β, γ (°) 90.0, 90.0, 120.0 90.0, 90.0, 90.0 90.0, 90.0, 120.0 
Resolution range (Å)a 36.4-1.90 (1.94-1.90) 48.4-3.00 (3.16-3.00) 85.2-2.75 (2.9-2.75) 
Rmergeab 0.129 (0.713) 0.098 (0.869) 0.117 
Rmeasac 0.137 (0.755) 0.115 (1.020) 0.219 (0.598) 
CC1/2ad 0.994 (0.643) 0.997 (0.448) 0.974 (0.577)  
Mean I/σI a 11.3 (3.4) 8.5 (1.7) 6.1 (2.8) 
Completeness (%) a 98.3 (98.3) 99.8 (99.9) 97.8 (95.9) 
Multiplicity a 9.1 (9.2) 3.6 (3.6) 5.5 (4.7) 
Wilson <B> (Å2) 19.1 95.1  
    
No. of twin domains 2   
Twin fractions (%) (h,k,l/-h,-k,l) 0.59/0.41   
    
Refinement     
Resolution range (Å) 36.4-1.90 48.4-3.00  
No. of reflections 78953 55431  
Rwork/Rfree 0.136/0.189 0.195/0.233  
Number of atoms    
Protein 8217 16523  
Ligand/ion 240 2  
Water 589 288  
B-factors (Å2) 28.0 92.6  
Rmsd from ideal values    
Bond lengths (Å) 0.020 0.010  
Bond angles (°) 2.11 1.38  
Ramachandran Plot    
Favoured region (%) 95.9 95.8  
Allowed (%) 3.4 3.4  
Outliers (%) 0.7 0.8  
Rotamer outliers (%) 2.1 2.1  
C-beta outliers 8 8  
PDB ID code    
 
a Values in parentheses are for the highest resolution shell. bRmerge = Σ(Ihl - <Ih>)/Σ(Ihl) where <Ih> is the mean 
intensity of unique reflection h, summed over all reflections for each observed intensity Ihl. cRmeas = Σ(n/n – 
1)1/2 (Ihl - <Ih>)/Σ(Ihl) where n is the number of observations for unique reflection h with mean intensity <Ih>, 
summed over all reflections for each observed intensity Ihl. dCC1/2 is the correlation coefficient on <I> between 
random halves of the dataset. Δanom, anomalous difference I+ - I-. 
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Supplemental Extended methods: 
 
Cloning and mutagenesis: 
Initially δ-COP (282-546) from S. cerevisiae was ligated into pQE-30 (Qiagen, Hilden, Germany) 
using BamH I and Pst I sites. This incorporated an N-terminal 6x histidine (His6) tag. Initial crystals 
of the His-tagged wild-type protein were obtained; however, these could not be solved by 
experimental phasing or molecular replacement (these crystals were subsequently solved by 
molecular replacement using the δ-COP-W404A structure, see Structure determination). 
Subsequently δ-COP-282-546 was sub-cloned into pGEX6P.1 (GE Healthcare, Waukesha, WI, 
USA) using BamH I and Not I sites incorporating a N-terminal, PreScission protease (GE 
Healthcare) cleavable GST tag. Purification using the GST tag increased the purity of δ-COP MHD. 
The W404A, and non-binding mutants were created using site-directed mutagenesis by overlap 
PCR using complementary primers with the relevant mutation(s) across the site of interest. All 
constructs were sequenced by Beckman Coulter Genomics prior to use. 
 
Protein expression and purification: 
All constructs were expressed at high levels in BL21(DE3)plysS cells (Novagen, Merck KGaA, 
Darmstadt, Germany). Five ml starter cultures were used to inoculate one liter flasks containing  
2xTY media and appropriate antibiotics. Cells were grown at 37°C to an OD600 between 0.6-1.0, 
before the temperature was decreased to 20°C for 1 h. After cooling, proteins were expressed 
overnight at 20°C following induction with 0.5 mM IPTG. After ~20 h of expression cells were 
harvested and resuspended in 20 mM HEPES pH 7.5, 500 mM NaCl, 5 mM β-ME, plus EDTA-free 
protease inhibitor tablets (1 tablet/50 ml buffer) (Roche Diagnostics GmbH, Mannheim, Germany).  
 
Selenomethionine substituted proteins were expressed in a methionine-auxotroph E. coli strain, 
B834(DE3)plysS (Novagen). Cells were grown in M9 media supplemented with the following; 
MgSO4 at 0.24 g/l (anhydrous), FeSO4.7H2O at 0.025 g/l, glucose at 0.4 % (w/v), vitamins at 0.0031 
g/l (containing Riboflavin, Niacinamide, Pyridoxine monohydrochloride and thiamine at a 10:10:1:10 
mass ratio), amino acids (-methionine) at 0.78 g/l (Complete Supplement Mixture Drop-Out: -Met 
(Formedium, Hunstanton, UK)), seleno-L-methionine at 0.04 g/l (plus appropriate antibiotics). All 
solutions added to media were sterile filtered, whereas amino acids were added directly as powder. 
Selenomethionine substituted proteins were expressed as for native proteins; however the cultures 
grew more slowly as expected. 
 
Cells were lysed using a disruptor (Constant Systems Ltd., Daventry, UK). Lysate containing His6-δ-
COP MHD was incubated for one hour at 4°C with 50% Ni-NTA agarose (Qiagen) in buffer, while 
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GST-tagged proteins were incubated with 50% glutathione sepharose slurry (GE Healthcare) in 
buffer. Protein bound to either matrix was washed extensively with >500 ml of buffer (20 mM 
HEPES pH 7.5, 700 mM NaCl, 5 mM β-ME). For His6-δ-COP-MHD, the wash buffer included 20 mM 
imidazole to remove contaminants that bind non-specifically to Ni-NTA beads. His6-δ-COP-MHD 
was eluted in batch in buffer containing 300 mM imidazole. GST-tagged proteins were cleaved 
overnight with human rhinovirus 3C protease (Prescission protease (GE Healthcare)) at 4°C and 
eluted in batch in buffer. Following elution, all proteins were concentrated for gel filtration on a Hi 
Load Superdex 75 16/60 prep grade size exclusion column (GE Healthcare) pre-equilibrated in the 
appropriate buffer: in 20 mM HEPES pH 7.5, 200 mM NaCl, 5 mM DTT (if the protein was to be 
used for crystallisation), or 50 mM HEPES pH 7.5, 200 mM NaCl, 5 mM β-ME (for ITC).  
The δ-COP-H350A-R384S-W404A mutant was determined to be folded as judged by circular 
dichroism and by identical gel filtration elution profiles as compared to W404A. 
 
Isothermal titration calorimetry (ITC): 
ITC experiments were conducted on a VP-ITC-200 isothermal titration calorimeter (GE Healthcare) 
at 20°C, using 20 injections of the sample in the syringe into the cell, with a 120 sec interval 
between injections. Each of these injections had a volume of 2 µl except for the first one, which only 
consisted of 0.5 µl. All components were in 50 mM HEPES pH 7.5, 200 mM NaCl, 5 mM β-ME. For 
all experiments the peptide was loaded into the syringe, and δ-COP MHD into the cell. A peptide 
into buffer run was subtracted from all runs to take into account the effect of peptide dilution. For all 
runs δ-COP MHD was at 50-150 µM; the concentration of the peptide was adjusted to ensure a 
significant number of points were on the binding curve, and that saturation was reached. Both 
protein and peptide (due to presence of tryptophans) concentrations were measured at 280 nm. 
Samples in both the cell and syringe were filtered using a Proteus Clarification Mini Spin Column 
(Generon, Maidenhead, UK), before loading. Titration data were analysed in ORIGIN to obtain 
values for stoichiometry (N), equilibrium dissociation constant (KD), and enthalpy of binding. All 
experiments were carried out at least three times with appropriate standard deviations reported. 
N.b. curves labelled as ‘WT’ in the main text were experiments done with W404A mutant. Likewise, 
‘H350A R384S’ also contained the W404A mutation. W404A was removed from the labeling to 
avoid adding complication in the main text. 
 
Extended structure determination procedures  
 
General data collection, data processing, and structure determination methods: 
Programs included in or affiliated with the CCP4 software package (43) were used for most steps 
during data processing and structure solution. The collected datasets were indexed and integrated 
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using Mosflm or Xia2, the Laue and point group determined with Pointless and the data scaled, 
merged and assessed using Scala or Aimless (43). Data were cut when the correlation coefficient 
(CC1/2) between half datasets equalled 0.5. autoSHARP (42) was used to search for heavy atoms 
and phasing. Solvent flipping was used to determine the hand of the substructure and to improve 
the phases. The structures could be built using the automated model building software, Buccaneer 
(44). Phaser (45) was employed for all molecular replacement work. The refinement of the models 
was done using iterative steps of model building in Coot (46) and in Refmac5 (47). Final model 
validation was undertaken using MolProbity (http://molprobity.biochem.duke.edu/). Images of the 
refined structures were prepared with the molecular graphic programs CCP4MG. The structures 
could be built using automated model building software, supplemented with manual rebuilding and 
automated refinement. 
 
Crystallisation of δ-COP MHD wildtype: 
Initially crystallisation trials were set up with the native N-terminally His-tagged wildtype protein 
alone, as well as in the presence of the Dsl1p WxxxW peptide. Crystals were only obtained of the 
protein alone; the best crystal was obtained at a protein concentration of 10 mg/ml in 0.1 M HEPES 
pH 7.0, 0.05 M CaCl2.2H2O, 2.2% (w/v) PEG-8000, 20% (v/v) Ethylene glycol by vapour diffusion. 
This crystal was cryoprotected in 30% (v/v) Ethylene glycol and flash cooled in liquid nitrogen. Data 
were collected to 3.0 Å and belonged to space group P212121 (Table S2). This crystal form could not 
be solved by molecular replacement using other known structures of Mu-homology domains, and 
despite soaking with various heavy atoms, no anomalous signal was visible to enable structure 
solution by experimental phasing.  
 
This crystal form was eventually solved by molecular replacement using the δ-COP-W404A 
structure as a model (see below). It has eight molecules in the asymmetric unit packed in a helical 
arrangement via the interaction between Trp-404 in one molecule, with pocket 1 in the tryptophan-
based motif binding site of another molecule. This explained the biophysical data showing that di-
tryptophan peptides bind to δ-COP MHD more tightly when this ‘back side’ tryptophan is mutated 
(data not shown). The final structure was refined to Rwork/Rfree values of 0.195/0.233 in Refmac5 
using local NCS restraints. Density representing residues 284-546 of δ-COP is visible in all eight 
molecules in asymmetric unit. Two calcium ions appear to be present (from the crystallisation 
condition), both of which bridge neighbouring molecules in the crystal. 
 
Crystallisation of native δ-COP-W404A with the Dsl1p WxW peptide: 
δ-COP MHD had a tendency to aggregate into larger oligomers, and binding to di-tryptophan 
peptides prevented this aggregation (highlighted during purification of protein-motif fusion 
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constructs). Modelling studies suggested that W404 in δ-COP MHD was exposed to solvent, and 
might be causing this aggregation, so we mutated W404 to alanine, and this appeared to prevent 
oligomerisation as assessed by gel filtration. The native δ-COP-W404A protein crystallised in the 
presence of the Dsl1p WxW peptide (DDWNWEVED) with the protein at 10 mg/ml, and the peptide 
at a 2:1 molar ratio by vapour diffusion, in 0.1 M HEPES pH 6.6, 2.8 M ammonium sulphate, and 
were cryoprotected in 4 M sodium formate, 0.05 M HEPES pH 6.6, 1.4 M ammonium sulphate, 1 
mM DDWNWEVED peptide. Data were collected to 1.8 Å resolution at Diamond Light Source, 
beamline I03 (Table S2). The L test and cumulative intensity distributions suggested that all crystals 
were perfect merohedral twins. All crystals belonged to apparent point group P622, with unit cell 
dimensions of a = 73 Å, b = 73 Å, c = 343 Å, α = 90°, β = 90°, γ = 120°, with an estimated two 
molecules in the asymmetric unit (44% solvent), or four molecules for a hemihedral twin. As 
reflections along the 0,0,l axis were present only when l=3n, the true space group would be one of 
P62, P64, P3121, P3221, P3112 or P3212. Molecular replacement was tried in all six possible space 
groups, using other known structures of MHDs as search models, however no believable solution 
was found. We failed to solve the structure by experimental phasing with Hg, presumably due to the 
twinning. Micro-seeding failed to produce untwinned crystals.   
This merohedrally twinned crystal form was eventually solved by molecular replacement using the 
δ-COP-W404A structure, solved by selenomethionine MAD (see below), as a model in space group 
P3121. Initially molecular replacement with Phaser (45) was carried out in all six possible space 
groups searching for one molecule (of an expected four), and plausible solutions were found in both 
P3121 and P3112. Second and third molecules were found in both of these space groups, however 
a fourth molecule was only found after removing a clashing loop (residues 459-465). The structure 
was refined with restrained amplitude-based twin refinement using Refmac (47): after one round the 
R factors clearly discriminated between space groups P3121 (Rwork;Rfree = 0.27; 0.33) and P3112 
(Rwork;Rfree = 0.34; 0.40). 
 
During refinement it became clear that the loop between strands 11 and 12 adopts a different 
conformation due to contacts with a neighbouring molecule in the crystal. This explained the failure 
of the molecular replacement to find all of the molecules using the initial unmodified model. It is not 
clear whether this conformational change has any functional role. Following refinement, the mFO-
DFC difference map showed clear electron density map representing the two tryptophans in the 
peptide (Figure S2F&G). The DDW413NW415EVED peptide was built (density for DW413NW415EV 
residues was visible) in the same orientation as the SeMet Dsl1p DDWNWE(SeMet)ED peptide, 
with the valine binding into pocket 3, however the density for Val-417 is poor and makes little 
contribution to binding, unlike the selenomethionine. The interactions between δ-COP and the 
native peptide are largely the same as with the SeMet-derivative peptide, preserving the tryptophan 
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orientations and the hydrogen bond interactions with side chains His-350, Asn-352, and Gly-381. 
The final structure was refined to Rwork/Rfree values of 0.136/0.189 using amplitude-based twin 
refinement and map sharpening in Refmac5 (47). Residues 412-417 of the peptide, and residues 
285-546 of δ-COP of the four molecules in asymmetric unit are visible, however the density for two 
loops is poor in some molecules (409-412 in chains A and D, 447-452 in chains B and D), and there 
are two breaks in the main chain at D/409, and B/451-452. 
 
Crystallisation of SeMet-substituted δ-COP-W404A bound to the Dsl1p SeMet-WxW peptide: 
Selenomethionine-substituted δ-COP-W404A was crystallised with a Dsl1p WxW peptide with 
selenomethionine replacing valine (DDWNWE(SeMet)ED) to aid identification of the orientation of 
the peptide. This peptide bound with an affinity similar to the native peptide (Figure S1). Crystals 
were obtained by vapour diffusion with 30 mg/ml protein, 2:1 molar ratio peptide:protein, in 0.1 M 
HEPES-Na pH 7.0, 0.15 M (NH4)2SO4, 21% (w/v) PEG-3350. Crystals grew after 2-3 days before 
degrading and eventually disappearing after ~7 days, and were therefore flash-cooled on day 3-4. 
Crystals were cryoprotected in 15% glycerol, 0.1 M HEPES-Na pH 7.0, 0.15 M (NH4)2SO4, 22% 
(w/v) PEG-3350, 1.5 mM DDWNWE(SeMet)ED peptide, and a three-wavelength MAD dataset was 
collected to 2.8 Å resolution at the selenium K edge (Table S1). After MAD phasing, the solvent 
content was optimised to 56% with eight molecules in the asymmetric unit (Figure S2). The initial 
atomic model was built automatically using Buccaneer (44) and refined against the high remote data 
set to 2.8 Å resolution using local NCS restraints, experimental phase restraints, and map 
sharpening in Refmac5 (47), with rebuilding in Coot (46). The two tryptophans on either side of His-
350, and the selenomethionine into pocket 3 of the peptide were clear even in the experimental 
phased maps prior to model building and refinement (Figure S2B&C), and the selenomethionine in 
the peptide was clear from the anomalous difference map (Figure S2C). The final structure was 
refined to final Rwork/Rfree values of 0.189/0.234. All nine residues of the peptide and residues 285-
546 of δ-COP are visible in all eight molecules in the asymmetric unit. However due to crystal 
contacts the density for four of the eight molecules (chains A-D) is better than for the other four 
(chains E-H); the density for some or all of residues 406-415, 437-466, and 482-493 (chain H) in 
these chains (E-H) is poor. 
 
Crystallisation of SeMet-substituted δ-COP-W404A with the Dsl1p WxxxW peptide: 
Selenomethionine-substituted δ-COP-W404A protein crystallised in the presence of the Dsl1p 
WxxxW peptide (ENAWDEAWAIDEC) with the protein at 15 mg/ml, and the peptide at a 2:1 molar 
ratio by vapour diffusion, in 0.1 M Bicine pH 9.0, 3.2 M ammonium sulphate, and were 
cryoprotected in 4 M sodium formate, 0.05 M Bicine pH 9.0, 1.7 M ammonium sulphate, 2 mM 
ENAWDEAWAIDEC peptide. Data were collected to 2.8 Å resolution at Diamond Light Source, 
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beamline I03 (Table S2). These crystals belonged to space group P3121, the same space group as 
with the native Dsl1p WxW peptide, but were not twinned. Following refinement the density 
representing the peptide was discontinuous, presumably due to low occupancy of the peptide, 
however the motif clearly binds at the same site and most likely in the same orientation (Figure S2). 
 
Crystallisation of SeMet-substituted δ-COP-W404A with the Gcs1p WxxF peptide: 
Following the observation that a WxxF peptide (DEDKWDDF) corresponding to the WxxF motif at 
the very C-terminus of Gcs1p binds to δ-COP MHD (Figure 4C), crystals of selenomethionine-
substituted δ-COP-MHD W404A were grown, using 20 mg/ml protein with the Gcs1p WxxF peptide 
(DEDKWDDF) added at a 2:1 molar ratio in 0.1 M Tris-HCl pH 8.5, 0.15 M magnesium chloride, 
26% (w/v) PEG-4000. The selenomethionine-substituted protein allowed use of the experimental 
phase information in refinement, which improved the connectivity of the density (particularly of the 
peptides). Crystals were obtained by vapour diffusion, cryoprotected with 15% glycerol, and data 
were collected to 2.5 Å resolution. These crystals belonged to space group P212121 (Table S1). This 
crystal form was solved by molecular replacement using one molecule of the previously determined 
structure, and had three molecules in the asymmetric unit. Following refinement the mFO-DFC 
difference map showed clear electron density representing the tryptophan and phenylalanine in the 
peptide (Figure S2H&I). The DEDKWDDF peptide binds in the same orientation as the Dsl1p 
WxWxφ peptides, with the tryptophan binding into pocket 1, and the phenylalanine in pocket 2. The 
tryptophan motif binding site is accessible in all three molecules in the asymmetric unit, however the 
electron density was better in one molecule (chain B) than in the other two, due to interactions of 
the peptide with a neighbouring molecule. Despite lower occupancy of the peptide bound to the 
other two molecules, the peptide appeared to bind in the same orientation. The structure was 
refined to final Rwork/Rfree values of 0.193/0.258 using TLS refinement, local NCS restraints, the SAD 
data directly, and map sharpening in Refmac5 (47). In the best molecule, all but the first two 
residues (DE) of the peptide could be built. 
 
Yeast Strains and Growth Media: 
The Saccharomyces cerevisiae strains Y7092 (MATa, his3Δ1 leu2Δ0 ura3Δ0 met15Δ0) and 
MY15059 (MATα, can1Δ::pSTE2-Sp_HIS5 his3∆1 lyp1Δ his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 dsl1ΔE-
natMX) (24) were used to study the δ-COP:Dsl1p interaction in vivo. Yeast strain PPY17:168 
(gcs1::URA3 glo3::HIS3 ura3 his3 leu2 trp1 ade2) harboring plasmids pGAL-GLO3 and either 
pPP16:100-5-GCS1-WF (i.e. wild-type GCS1), pPP16:100-12-gcs1-AA (the gcs1 mutant carrying 
the W349A, F352A mutations), or empty-vector pRS315 was used to study the δ-COP:Gcs1p 
interaction in vivo. Yeast cells were grown aerobically at 30°C, unless otherwise noted. YEPD rich 
media contained yeast extract (1% w/v), peptone (2% w/v), and glucose (2% w/v). Sporulation 
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media (SPM) contained potassium acetate (0.3% w/v) and raffinose (0.02% w/v) and was 
supplemented with histidine, leucine, methionine, and uracil (0.03% w/v each). YEPD+Nat media 
contained 100 µg/ml nourseothricin (clonNAT). 
 
 
